Terms: = Prostate cancer AND POU5F1, MGC22487, 5460, ENSG00000230336, POU5F1P1, OTF3P1, Oct4, OCT4, OCT3, OTF3C, OTF4, OTF3 AND Treatment
50 results:
1. prostate cancer Stem Cells: Biology and treatment Implications.
Koukourakis IM; Platoni K; Kouloulias V; Arelaki S; Zygogianni A
Int J Mol Sci; 2023 Oct; 24(19):. PubMed ID: 37834336
[TBL] [Abstract] [Full Text] [Related]
2. Transposable Elements Are Co-opted as Oncogenic Regulatory Elements by Lineage-Specific Transcription Factors in prostate cancer.
Grillo G; Keshavarzian T; Linder S; Arlidge C; Mout L; Nand A; Teng M; Qamra A; Zhou S; Kron KJ; Murison A; Hawley JR; Fraser M; van der Kwast TH; Raj GV; He HH; Zwart W; Lupien M
Cancer Discov; 2023 Nov; 13(11):2470-2487. PubMed ID: 37694973
[TBL] [Abstract] [Full Text] [Related]
3. Total flavonoids of Litchi seed attenuate stem cell-like properties in breast cancer by regulating Notch3 signaling pathway.
Liao Y; Luo Z; Liu Y; Xue W; He S; Chen X; Ren H; Yang X; Zhu D; Su Z; Huang Q; Guo H
J Ethnopharmacol; 2023 Apr; 305():116133. PubMed ID: 36603788
[TBL] [Abstract] [Full Text] [Related]
4. DNA barcoding and gene expression recording reveal the presence of cancer cells with unique properties during tumor progression.
Umeki Y; Ogawa N; Uegaki Y; Saga K; Kaneda Y; Nimura K
Cell Mol Life Sci; 2022 Dec; 80(1):17. PubMed ID: 36564568
[TBL] [Abstract] [Full Text] [Related]
5. Counterintuitive production of tumor-suppressive secretomes from oct4- and c-Myc-overexpressing tumor cells and MSCs.
Li K; Sun X; Zha R; Liu S; Feng Y; Sano T; Aryal UK; Sudo A; Li BY; Yokota H
Theranostics; 2022; 12(7):3084-3103. PubMed ID: 35547745
[No Abstract] [Full Text] [Related]
6. Role of Resveratrol as Radiosensitizer by Targeting cancer Stem Cells in Radioresistant prostate cancer Cells (PC-3).
El-Benhawy SA; Morsi MI; Fahmy EI; Soula MA; Khalil FAZF; Arab AR
Asian Pac J Cancer Prev; 2021 Dec; 22(12):3823-3837. PubMed ID: 34967561
[TBL] [Abstract] [Full Text] [Related]
7. Subtype-specific collaborative transcription factor networks are promoted by oct4 in the progression of prostate cancer.
Takayama KI; Kosaka T; Suzuki T; Hongo H; Oya M; Fujimura T; Suzuki Y; Inoue S
Nat Commun; 2021 Jun; 12(1):3766. PubMed ID: 34145268
[TBL] [Abstract] [Full Text] [Related]
8. Long non-coding RNA LINC00649 regulates YES-associated protein 1 (YAP1)/Hippo pathway to accelerate gastric cancer (GC) progression via sequestering miR-16-5p.
Wang H; Di X; Bi Y; Sun S; Wang T
Bioengineered; 2021 Dec; 12(1):1791-1802. PubMed ID: 33975517
[TBL] [Abstract] [Full Text] [Related]
9. [Pathological features of primary extragonadal germ cell tumor of the prostate with small round blue cell morphology].
Gan HL; Wang QF
Zhonghua Bing Li Xue Za Zhi; 2021 Feb; 50(2):108-113. PubMed ID: 33535304
[No Abstract] [Full Text] [Related]
10. The nicotinamide phosphoribosyltransferase antagonist FK866 inhibits growth of prostate tumour spheroids and increases doxorubicin retention without changes in drug transporter and cancer stem cell protein expression.
Sauer H; Kampmann H; Khosravi F; Sharifpanah F; Wartenberg M
Clin Exp Pharmacol Physiol; 2021 Mar; 48(3):422-434. PubMed ID: 33349973
[TBL] [Abstract] [Full Text] [Related]
11. Androgen Deprivation Induces Transcriptional Reprogramming in prostate cancer Cells to Develop Stem Cell-Like Characteristics.
Verma S; Shankar E; Kalayci FNC; Mukunda A; Alassfar M; Singh V; Chan ER; MacLennan GT; Gupta S
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33339129
[TBL] [Abstract] [Full Text] [Related]
12. Androgen Deprivation Induces Reprogramming of prostate cancer Cells to Stem-Like Cells.
Sánchez BG; Bort A; Vara-Ciruelos D; Díaz-Laviada I
Cells; 2020 Jun; 9(6):. PubMed ID: 32531951
[TBL] [Abstract] [Full Text] [Related]
13. Eprinomectin, a novel semi-synthetic macrocylic lactone is cytotoxic to PC3 metastatic prostate cancer cells via inducing apoptosis.
Samy ALPA; Bakthavachalam V; Vudutha M; Vinjamuri S; Chinnapaka S; Munirathinam G
Toxicol Appl Pharmacol; 2020 Aug; 401():115071. PubMed ID: 32454055
[TBL] [Abstract] [Full Text] [Related]
14. PIM protein kinases regulate the level of the long noncoding RNA H19 to control stem cell gene transcription and modulate tumor growth.
Singh N; Padi SKR; Bearss JJ; Pandey R; Okumura K; Beltran H; Song JH; Kraft AS; Olive V
Mol Oncol; 2020 May; 14(5):974-990. PubMed ID: 32146726
[TBL] [Abstract] [Full Text] [Related]
15. Apigenin as an anticancer agent.
Imran M; Aslam Gondal T; Atif M; Shahbaz M; Batool Qaisarani T; Hanif Mughal M; Salehi B; Martorell M; Sharifi-Rad J
Phytother Res; 2020 Aug; 34(8):1812-1828. PubMed ID: 32059077
[TBL] [Abstract] [Full Text] [Related]
16. Secreted protein acidic and rich in cysteine promotes epithelial-mesenchymal transition of hepatocellular carcinoma cells and acquisition of cancerstem cell phenotypes.
Jiang X; Liu F; Wang Y; Gao J
J Gastroenterol Hepatol; 2019 Oct; 34(10):1860-1868. PubMed ID: 31041810
[TBL] [Abstract] [Full Text] [Related]
17. Moderately Hypofractionated Radiotherapy in Node-positive prostate cancer.
Mallick I; Das A; Arunsingh M
Clin Oncol (R Coll Radiol); 2019 Apr; 31(4):260-264. PubMed ID: 30718087
[TBL] [Abstract] [Full Text] [Related]
18. DDR1 regulates thyroid cancer cell differentiation via IGF-2/IR-A autocrine signaling loop.
Vella V; Nicolosi ML; Cantafio P; Massimino M; Lappano R; Vigneri P; Ciuni R; Gangemi P; Morrione A; Malaguarnera R; Belfiore A
Endocr Relat Cancer; 2019 Jan; 26(1):197-214. PubMed ID: 30121624
[TBL] [Abstract] [Full Text] [Related]
19. Loss of MAOA in epithelia inhibits adenocarcinoma development, cell proliferation and cancer stem cells in prostate.
Liao CP; Lin TP; Li PC; Geary LA; Chen K; Vaikari VP; Wu JB; Lin CH; Gross ME; Shih JC
Oncogene; 2018 Sep; 37(38):5175-5190. PubMed ID: 29844571
[TBL] [Abstract] [Full Text] [Related]
20. Acquisition of tumorigenic potential and therapeutic resistance in CD133+ subpopulation of prostate cancer cells exhibiting stem-cell like characteristics.
Kanwal R; Shukla S; Walker E; Gupta S
Cancer Lett; 2018 Aug; 430():25-33. PubMed ID: 29775627
[TBL] [Abstract] [Full Text] [Related]
[Next]